These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 20212083)

  • 1. The evolution of cancer modeling: the shadow of stem cells.
    Vicente-Dueñas C; Cobaleda C; Pérez-Losada J; Sánchez-García I
    Dis Model Mech; 2010; 3(3-4):149-55. PubMed ID: 20212083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maximizing mouse cancer models.
    Frese KK; Tuveson DA
    Nat Rev Cancer; 2007 Sep; 7(9):645-58. PubMed ID: 17687385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer as a reprogramming-like disease: implications in tumor development and treatment.
    Castellanos A; Vicente-Dueñas C; Campos-Sánchez E; Cruz JJ; García-Criado FJ; García-Cenador MB; Lazo PA; Pérez-Losada J; Sánchez-García I
    Semin Cancer Biol; 2010 Apr; 20(2):93-7. PubMed ID: 20188174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumoral stem cell reprogramming as a driver of cancer: Theory, biological models, implications in cancer therapy.
    Vicente-Dueñas C; Hauer J; Ruiz-Roca L; Ingenhag D; Rodríguez-Meira A; Auer F; Borkhardt A; Sánchez-García I
    Semin Cancer Biol; 2015 Jun; 32():3-9. PubMed ID: 24530939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neural and cancer stem cells in tumor suppressor mouse models of malignant astrocytoma.
    Llaguno SA; Chen J; Kwon CH; Parada LF
    Cold Spring Harb Symp Quant Biol; 2008; 73():421-6. PubMed ID: 19022744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem cell plasticity in development and cancer: epigenetic origin of cancer stem cells.
    Shah M; Allegrucci C
    Subcell Biochem; 2013; 61():545-65. PubMed ID: 23150267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Good cells gone bad: the cellular origins of cancer.
    Wang JC
    Trends Mol Med; 2010 Mar; 16(3):145-51. PubMed ID: 20149745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concerns about targeting cancer stem cell for cancer therapy.
    Yang G; Lu X; Fu H; Jin L; Yao L; Lu Z
    Med Hypotheses; 2011 Mar; 76(3):457. PubMed ID: 21288650
    [No Abstract]   [Full Text] [Related]  

  • 9. Roots and stems: stem cells in cancer.
    Polyak K; Hahn WC
    Nat Med; 2006 Mar; 12(3):296-300. PubMed ID: 16520777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling Cancer-Associated Mutations of PTEN in Mice.
    Papa A; Pandolfi PP
    Methods Mol Biol; 2016; 1388():289-306. PubMed ID: 27033081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer stem cells and oncology therapeutics.
    Al-Hajj M
    Curr Opin Oncol; 2007 Jan; 19(1):61-4. PubMed ID: 17133114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cell microRNAs in senescence and immortalization: novel players in cancer therapy.
    Leal JA; Feliciano A; Lleonart ME
    Med Res Rev; 2013 Jan; 33(1):112-38. PubMed ID: 21793013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical in vitro models from genetically engineered mice for breast and colon cancer (Review).
    Telang N; Katdare M
    Oncol Rep; 2011 May; 25(5):1195-201. PubMed ID: 21399881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer stem cells: at the headwaters of tumor development.
    Ward RJ; Dirks PB
    Annu Rev Pathol; 2007; 2():175-89. PubMed ID: 18039097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer stem cells in solid tumors.
    Er O
    Onkologie; 2009 Oct; 32(10):605-9. PubMed ID: 19816080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New cancer diagnostics and therapeutics from a ninth 'hallmark of cancer': symmetric self-renewal by mutated distributed stem cells.
    Sherley JL
    Expert Rev Mol Diagn; 2013 Nov; 13(8):797-810. PubMed ID: 24151848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.
    Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R
    J Natl Cancer Inst; 2007 Nov; 99(22):1668-82. PubMed ID: 18000218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetically engineered knock-in and conditional knock-in mouse models of cancer.
    Rappaport A; Johnson L
    Cold Spring Harb Protoc; 2014 Sep; 2014(9):897-911. PubMed ID: 25183823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse models for human lung cancer.
    Meuwissen R; Berns A
    Genes Dev; 2005 Mar; 19(6):643-64. PubMed ID: 15769940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic stability of human embryonic stem cells: A first-step toward the development of potential hESC-based systems for modeling childhood leukemia.
    Catalina P; Bueno C; Montes R; Nieto A; Ligero G; Sanchez L; Jara M; Rasillo A; Orfao A; Cigudosa J; Hovatta O; Greaves M; Menendez P
    Leuk Res; 2009 Jul; 33(7):980-90. PubMed ID: 18930318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.